Scientists studying a hard-to-treat form of blood cancer called acute myeloid leukemia (AML) have found that a type of ...

A new study by Indiana University School of Medicine researchers has revealed a breakthrough in the fight against acute ...

Researchers conducted a retrospective study published in July 2025 issue of Journal of Hematology & Oncology to examine the ...

Acute myeloid leukaemia (AML) starts when the DNA and genes in the stem cells of the bone marrow undergo change known as genetic mutation. This leads to uncontrolled growth and proliferation of ...

Acute myeloid leukemia (AML) is a type of blood cancer. Most of the time, chemotherapy is the first treatment. AML is a fast-growing cancer, so treatment needs to be started quickly.

"CAR T drives acute myeloid leukemia into submission in pre-clinical studies." ScienceDaily. ScienceDaily, 28 April 2022. <www.sciencedaily.com / releases / 2022 / 04 / 220428125358.htm>.

The Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for decitabine/cedazuridine plus venetoclax to treat adults with newly diagnosed acute myeloid leukemia ...

Symptoms of Secondary Acute Myeloid Leukemia Secondary AML causes the same symptoms as AML. Most symptoms happen when your blood cell counts drop. They depend on the type of blood cell affected.

Acute myeloid leukemia (AML) is the most common acute leukemia in adults, with an incidence of over 20 000 cases per year in the United States alone. Large chromosomal translocations as well as ...

Adverse-Risk Acute Myeloid Leukemia Gail J. Roboz, MD; Alexander Perl, MD Disclosures June 16, 2022 0 ...